Get the Stockscreener App
19.87
2.42%
0.47
Instil Bio Inc stock is traded at $19.87, with a volume of 48,699.
It is up +2.42% in the last 24 hours and up +17.37% over the past month.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
See More
Previous Close:
$19.40
Open:
$19.5
24h Volume:
48,699
Relative Volume:
0.35
Market Cap:
$134.14M
Revenue:
-
Net Income/Loss:
$-74.14M
P/E Ratio:
-1.7445
EPS:
-11.39
Net Cash Flow:
$-65.70M
1W Performance:
-1.58%
1M Performance:
+17.37%
6M Performance:
+55.48%
1Y Performance:
-36.03%
1-Day Range:
$19.15
$20.11
1-Week Range:
$18.10
$20.32
52-Week Range:
$10.80
$44.50
Instil Bio Inc Stock (TIL) Company Profile
Name
Instil Bio Inc
Sector
Industry
Phone
(972) 499-3350
Address
3963 MAPLE AVENUE, DALLAS
Compare TIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
19.87 | 130.96M | 0 | -74.14M | -65.70M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.17 | 108.04B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
478.58 | 60.75B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.31 | 61.26B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
829.83 | 50.32B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
164.02 | 33.75B | 398.11M | -1.03B | -868.57M | -5.7032 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-25 | Upgrade | Jefferies | Hold → Buy |
| Nov-04-24 | Initiated | JMP Securities | Mkt Perform |
| Apr-12-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-01-22 | Downgrade | Truist | Buy → Hold |
| Aug-13-21 | Initiated | Robert W. Baird | Outperform |
| Apr-13-21 | Initiated | Cowen | Outperform |
| Apr-13-21 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-21 | Initiated | Truist | Buy |
View All
Instil Bio Inc Stock (TIL) Latest News
Will Instil Bio Inc. stock benefit from automationWeekly Loss Report & Consistent Return Investment Signals - newser.com
How Instil Bio Inc. stock reacts to job market dataWeekly Volume Report & Technical Pattern Recognition Alerts - newser.com
Why Instil Bio Inc. stock remains on buy listsEarnings Recap Summary & AI Enhanced Trading Alerts - newser.com
Regression analysis insights on Instil Bio Inc. performanceWatch List & Fast Moving Stock Trade Plans - newser.com
Why Instil Bio Inc. stock appeals to analystsStop Loss & Stepwise Swing Trade Plans - newser.com
What to expect from Instil Bio Inc. in the next 30 daysPortfolio Performance Report & AI Forecasted Entry/Exit Points - newser.com
Instil Bio’s AXN-2510 Study: A Promising Step in Cancer Treatment - TipRanks
Why Instil Bio Inc. stock could benefit from AI revolution2025 Market Outlook & Expert Curated Trade Setups - newser.com
Evaluating Instil Bio Inc. with trendline analysisEarnings Performance Report & Weekly High Return Stock Forecasts - newser.com
Is Instil Bio Inc. showing signs of accumulationMarket Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Key metrics from Instil Bio Inc.’s quarterly dataMarket Rally & Growth Oriented Trade Recommendations - newser.com
Published on: 2025-10-27 00:12:39 - newser.com
What analysts say about Instil Bio Inc stockPortfolio Diversification Tips & Low Cost Portfolio Growth - earlytimes.in
Will Instil Bio Inc. stock maintain momentum in 2025Insider Selling & Smart Allocation Stock Tips - newser.com
Instil Bio Inc Stock (TIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
2.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):